A prospective study to compare the effectiveness of giving normal release morphine sulphate overnight on a regular 4 hourly basis or on an 'as required basis' in patients with cancer
Not Applicable
Completed
- Conditions
- Cancer: Pain managementCancerMalignant neoplasm without specification of site
- Registration Number
- ISRCTN90932532
- Lead Sponsor
- Department of Health (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 85
Inclusion Criteria
Multicentre 85 patients.
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To provide an evidence base for overnight administration regimes for patients receiving normal release morphine for cancer pain.
- Secondary Outcome Measures
Name Time Method ot provided at time of registration